🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to examine how effective rituximab or tocilizu...
Status
Active Not Recruiting
Location
Johns Hopkins
Start Date
2020-09-25
Trial ID
NCT04375228
Treatments Being Tested
This is a prospective Phase II study evaluating Siltuximab for CRS and ICAN...
Status
Recruiting
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Start Date
2025-08-10
Trial ID
NCT07106671
Treatments Being Tested
Interleukin-6 (IL-6), a pro-inflammatory cytokine, has been found to have a...
Status
Unknown
Location
Fabrizio Cantini
Start Date
2015-01-01
Trial ID
NCT03244709
Treatments Being Tested
Background: X-Linked Chronic Granulomatous Disease (X-CGD) is caused by a ...
Status
Enrolling By Invitation
Location
National Institutes of Health Clinical Center
Start Date
2025-09-10
Trial ID
NCT07113743
The Women's Ischemia Study Evaluation (WISE), a cohort study of over 1000 w...
Status
Recruiting
Location
Cedars-Sinai Women's Heart Center
Start Date
2015-10
Trial ID
NCT02582021
This study will assess the efficacy and safety of mosunetuzumab in combinat...
Status
Active Not Recruiting
Location
City of Hope Cancer Center
Start Date
2022-04-25
Trial ID
NCT05171647
Treatments Being Tested
Magnetic Resonance Angiography (MRA) is an examination similar to Magnetic ...
Status
Completed
Location
Amersham Buchler GmbH & Co. KG
Start Date
2003-09
Trial ID
NCT00209391
Treatments Being Tested
The purpose of this study is to find out whether the study drug tocilizumab...
Status
Terminated
Location
Memorial Sloan Kettering Cancer Center
Start Date
2020-05-01
Trial ID
NCT04377659
Treatments Being Tested
This randomized, double-blind, parallel group study compares the efficacy a...
Status
Completed
Location
Multiple Locations
Start Date
2010-09
Trial ID
NCT01194414
This is an open-label, extension, Phase III study to evaluate the long-term...
Status
Completed
Location
Multiple Locations
Start Date
2005-02
Trial ID
NCT00144625
Treatments Being Tested